Wan J. et al. (2010) indicate that the PPARγ rs3856806 polymorphism may reduce the risk of severe atherogenesis by modulation of adipose metabolism in Chinese patients with CAD [58]. The gene discussed is PPARG; the disease is coronary artery disorder.